Global oil demand will return to pre-pandemic levels in two years and reach record heights by 2026 unless governments take swift action to meet climate goals, the International Energy Agency said on Wednesday. Oil markets and the world economy
Many countries in the European Unions, including France, Norway Bulgaria and Germany, have stopped the use of the Oxford AstraZeneca vaccine, on the grounds that it leads to blood clotting and may be unsafe for some age categories. Nevertheless,
Malaysia’s Prime Minister Muhyiddin Yassin unveiled a fresh round of stimulus on Wednesday, in the hope of breathing life into a pandemic-hit economy that last year saw its worst contraction since the Asian Financial Crisis.
After four years of the Brexit saga, the last few weeks have been a period of respite. The consequences of leaving the “transition period” at the end of January have not just been overshadowed by the pandemic, but also by the royal family’s real
Vaccine nationalism is a new concept in the current COVID-19 era, which is likely to hinder the global health and economic recovery causing more harm than the pandemic itself. Governments are scrambling to acquire vaccines for their populations
For the study, published in the journal BMC Pregnancy and Childbirth, the team analysed survey responses from more than 160 pregnant and post-partum women.
The UAE has been playing a stellar role in not just containing the spread of COVID-19 but in being a leader as far as vaccination initiatives go. The recently launched Wellness on Wheels (WoW) drive which is providing COVID-19 vaccination
A year into the pandemic, infection rates are falling. Hospitals are quieter; morgues are emptier. Emboldened by vaccines, we’re dropping our masks and stepping closer. Slowly we’re reopening indoor dining, theaters, museums and schools.
Across Britain, some people who have been counting down the days to their first COVID-19 jab are suddenly suffering doubts – among them my wife, Rachel, who was due to have it on Tuesday. The suspension of the roll out of the Oxford/AstraZeneca